Literature DB >> 12519560

Local corticosteroid injection for carpal tunnel syndrome.

S Marshall1, G Tardif, N Ashworth.   

Abstract

BACKGROUND: Carpal tunnel syndrome is a clinical syndrome manifested by signs and symptoms of irritation of the median nerve at the level of the carpal tunnel in the wrist. Local corticosteroid injection for carpal tunnel syndrome has been studied but its effectiveness and duration of benefit of local corticosteroid injection for Carpal tunnel syndrome remain unknown.
OBJECTIVES: To evaluate the effectiveness of local steroid injection for carpal tunnel syndrome versus placebo injection or other non-surgical interventions in improving clinical outcome and to determine the length of symptom relief. SEARCH STRATEGY: We searched the Cochrane Neuromuscular Disease Group register (searched June 2002), MEDLINE (searched January 1966 to May 2002), EMBASE (searched January 1980 to May 2002)and CINAHL(searched January 1982 to May 2002). SELECTION CRITERIA: We included randomized or quasi-randomized studies of participants with carpal tunnel syndrome treated with local corticosteroid injection. The primary outcome measure was clinical improvement. DATA COLLECTION AND ANALYSIS: Three reviewers independently selected the trials to be included rated for their overall quality. Relative risks and 95% confidence intervals were calculated for each trial and summary relative risks and 95% confidence intervals were also calculated. MAIN
RESULTS: We identified nine randomized controlled trials. Four were excluded. One trial demonstrated clinical improvement of carpal tunnel syndrome at one month following local corticosteroid compared to placebo injection (Relative risk 3.83 (95% confidence intervals 1.82 to 8.05)). One trial compared local corticosteroid injection to oral steroid and at three months after treatment there was a significant improvement in the injection group (mean difference -7.00 (95% confidence intervals -11.58 to -2.42)). In one trial the rate of improvement after one month was greater after local than systemic corticosteroid injection (Relative risk 3.17(95% confidence intervals 1.02 to 9.87)). In one trial symptoms did not improve significantly for the injection group at eight weeks after injection compared to treatment with anti-inflammatory medication and splinting (mean difference 0.10 (95% confidence intervals -0.33 to 0.53)). Although local steroid injection did provide benefit compared to Helium-Neon Laser treatment at two weeks after onset of treatment (Relative risk 0.27 (95% CI 0.09 to 0.83), this effect did not hold at six months follow-up (Relative risk 0.76 (95% confidence intervals 0.48 to 1.21). REVIEWER'S
CONCLUSIONS: Local corticosteroid injection for carpal tunnel syndrome provides greater clinical improvement in symptoms one month after injection compared to placebo. Symptom relief beyond one month compared to placebo has not been demonstrated. Local corticosteroid injection provides significantly greater clinical improvement compared to oral steroid up to three months after treatment. Local corticosteroid injection does not provide improved clinical outcome compared to either anti-inflammatory treatment and splinting after eight weeks or Helium -Neon laser treatment after six months.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12519560     DOI: 10.1002/14651858.CD001554

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  13 in total

Review 1.  What can family physicians offer patients with carpal tunnel syndrome other than surgery? A systematic review of nonsurgical management.

Authors:  Felicity Goodyear-Smith; Bruce Arroll
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

2.  The role of job strain on return to work after carpal tunnel surgery.

Authors:  D Gimeno; B C Amick; R V Habeck; J Ossmann; J N Katz
Journal:  Occup Environ Med       Date:  2005-11       Impact factor: 4.402

3.  Transforaminal steroid injections for the treatment of cervical radiculopathy: a prospective and randomised study.

Authors:  Leif Anderberg; Mårten Annertz; Liselott Persson; Lennart Brandt; Hans Säveland
Journal:  Eur Spine J       Date:  2006-07-12       Impact factor: 3.134

4.  A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study.

Authors:  Srinivas Nalamachu; R S Crockett; Arnold R Gammaitoni; Errol M Gould
Journal:  MedGenMed       Date:  2006-08-09

5.  Effect of vitamin b6 on clinical symptoms and electrodiagnostic results of patients with carpal tunnel syndrome.

Authors:  Mahnaz Talebi; Sasan Andalib; Shohreh Bakhti; Hormoz Ayromlou; Alireza Aghili; Ashraf Talebi
Journal:  Adv Pharm Bull       Date:  2013-08-20

6.  Incidence of common compressive neuropathies in primary care.

Authors:  R Latinovic; M C Gulliford; R A C Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

7.  Progesterone - new therapy in mild carpal tunnel syndrome? Study design of a randomized clinical trial for local therapy.

Authors:  Paolo Milani; Mauro Mondelli; Federica Ginanneschi; Riccardo Mazzocchio; Alessandro Rossi
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2010-04-26

Review 8.  Surgical treatment options for carpal tunnel syndrome.

Authors:  R J P M Scholten; A Mink van der Molen; B M J Uitdehaag; L M Bouter; H C W de Vet
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

9.  Health-related quality of life as a main determinant of access to rheumatologic care.

Authors:  Leticia Leon; Juan Angel Jover; Estibaliz Loza; Maria Victoria Zunzunegui; Cristina Lajas; Cristina Vadillo; Oscar Fontsere; Luis Rodriguez-Rodriguez; Cristina Martinez; Benjamin Fernandez-Gutierrez; Lydia Abasolo
Journal:  Rheumatol Int       Date:  2013-01-11       Impact factor: 2.631

10.  Effect of Linum usitatissimum L. (linseed) oil on mild and moderate carpal tunnel syndrome: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Mohammad Hashem Hashempur; Kaynoosh Homayouni; Alireza Ashraf; Alireza Salehi; Mohsen Taghizadeh; Mojtaba Heydari
Journal:  Daru       Date:  2014-05-21       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.